Mid‐ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: An important subtype of arrhythmogenic cardiomyopathy
Li Cui(Wuhan University of Science and Technology), Tong Liu(Second Hospital of Tianjin Medical University), Gary Tse(Observational & Pragmatic Research Institute), George Bazoukis(Evangelismos Hospital), Leonardo Roever(University of Washington), Guangping Li(Qingdao University), Panagiotis Korantzopoulos(University of Ioannina), Zhiqiang Zhao(Shenyang Pharmaceutical University), Κonstantinos P. Letsas(Evangelismos Hospital)
Cited by 20
Related Papers
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016
|The Lancet|2018|460
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats
|Cardiovascular Diabetology|2019|296
Association Between C-Reactive Protein and Recurrence of Atrial Fibrillation After Successful Electrical Cardioversion
|Journal of the American College of Cardiology|2007|271